BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 12081632)

  • 1. Bayesian population model of methotrexate to guide dosage adjustments for folate rescue in patients with breast cancer.
    Monjanel-Mouterde S; Lejeune C; Ciccolini J; Merite N; Hadjaj D; Bonnier P; Piana P; Durand A
    J Clin Pharm Ther; 2002 Jun; 27(3):189-95. PubMed ID: 12081632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose methotrexate in adults with osteosarcoma: a population pharmacokinetics study and validation of a new limited sampling strategy.
    Dupuis C; Mercier C; Yang C; Monjanel-Mouterde S; Ciccolini J; Fanciullino R; Pourroy B; Deville JL; Duffaud F; Bagarry-Liegey D; Durand A; Iliadis A; Favre R
    Anticancer Drugs; 2008 Mar; 19(3):267-73. PubMed ID: 18510172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of methotrexate elimination after high dose infusion in children with acute lymphoblastic leukaemia using a population pharmacokinetic approach.
    Odoul F; Le Guellec C; Lamagnère JP; Breilh D; Saux MC; Paintaud G; Autret-Leca E
    Fundam Clin Pharmacol; 1999; 13(5):595-604. PubMed ID: 10520733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetics of high-dose methotrexate in children with acute lymphoblastic leukaemia.
    Aumente D; Buelga DS; Lukas JC; Gomez P; Torres A; García MJ
    Clin Pharmacokinet; 2006; 45(12):1227-38. PubMed ID: 17112298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Individual dose adjustment of high-dose methotrexate in clinical practice].
    Bagarry-Liégey D; Nicoara A; Duffaud F; Guillet P; Pignon T; Catalin J; Durand A; Favre R
    Rev Med Interne; 1996; 17(8):689-98. PubMed ID: 8881200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotoxicity after high-dose methotrexate (MTX) is adequately explained by insufficient folinic acid rescue.
    Cohen IJ
    Cancer Chemother Pharmacol; 2017 Jun; 79(6):1057-1065. PubMed ID: 28455583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic study of methotrexate, folinic acid and their serum metabolites in children treated with high-dose methotrexate and leucovorin rescue.
    Wolfrom C; Hepp R; Hartmann R; Breithaupt H; Henze G
    Eur J Clin Pharmacol; 1990; 39(4):377-83. PubMed ID: 2076721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Investigation on individualized adjustment of target range of high-dose methotrexate].
    Hua Y; Zhao WH; Lu XT; Yang LH; Lu W
    Zhonghua Er Ke Za Zhi; 2008 Mar; 46(3):203-8. PubMed ID: 19099710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating performance of a decision support system to improve methotrexate pharmacotherapy in children and young adults with cancer.
    Dombrowsky E; Jayaraman B; Narayan M; Barrett JS
    Ther Drug Monit; 2011 Feb; 33(1):99-107. PubMed ID: 21192315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenging the clinical relevance of folinic acid over rescue after high dose methotrexate (HDMTX).
    Cohen IJ
    Med Hypotheses; 2013 Nov; 81(5):942-7. PubMed ID: 24035689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetics of high-dose methotrexate in Japanese adult patients with malignancies: a concurrent analysis of the serum and urine concentration data.
    Fukuhara K; Ikawa K; Morikawa N; Kumagai K
    J Clin Pharm Ther; 2008 Dec; 33(6):677-84. PubMed ID: 19138246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetic study of methotrexate in children with acute lymphoblastic leukemia.
    Zhang C; Zhai S; Yang L; Wu H; Zhang J; Ke X
    Int J Clin Pharmacol Ther; 2010 Jan; 48(1):11-21. PubMed ID: 20040335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose methotrexate therapy of childhood acute lymphoblastic leukemia: lack of relation between serum methotrexate concentration and creatinine clearance.
    Joannon P; Oviedo I; Campbell M; Tordecilla J
    Pediatr Blood Cancer; 2004 Jul; 43(1):17-22. PubMed ID: 15170885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: is intrathecal chemotherapy necessary?
    Glantz MJ; Cole BF; Recht L; Akerley W; Mills P; Saris S; Hochberg F; Calabresi P; Egorin MJ
    J Clin Oncol; 1998 Apr; 16(4):1561-7. PubMed ID: 9552066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosage adjustment of high-dose methotrexate using Bayesian estimation: a comparative study of two different concentrations at the end of 8-h infusions.
    Pignon T; Lacarelle B; Duffaud F; Guillet P; Catalin J; Durand A; Favre R
    Ther Drug Monit; 1995 Oct; 17(5):471-8. PubMed ID: 8585110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Memorial Sloan Kettering Cancer Center experience with outpatient administration of high dose methotrexate with leucovorin rescue.
    Zelcer S; Kellick M; Wexler LH; Gorlick R; Meyers PA
    Pediatr Blood Cancer; 2008 Jun; 50(6):1176-80. PubMed ID: 18266225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [l-folinic acid versus racemic folinic acid in the treatment of leukemia in children with high dose of methotrexate].
    Etienne MC; Thyss A; Bertrand Y; Rubie H; Milano G
    Bull Cancer; 1993 Apr; 80(4):357-63. PubMed ID: 8173189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. l-folinic acid versus d,l-folinic acid in rescue of high-dose methotrexate therapy in children.
    Etienne MC; Thyss A; Bertrand Y; Touraine R; Rubie H; Robert A; Milano G
    J Natl Cancer Inst; 1992 Aug; 84(15):1190-5. PubMed ID: 1635087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical relations of methotrexate pharmacokinetics in the treatment for pediatric osteosarcoma.
    Hegyi M; Gulácsi A; Cságoly E; Csordás K; Eipel OT; Erdélyi DJ; Müller J; Nemes K; Lautner-Csorba O; Kovács GT
    J Cancer Res Clin Oncol; 2012 Oct; 138(10):1697-702. PubMed ID: 22652833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetic study of methotrexate in patients with lymphoid malignancy.
    Faltaos DW; Hulot JS; Urien S; Morel V; Kaloshi G; Fernandez C; Xuan kH; Leblond V; Lechat P
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):626-33. PubMed ID: 16528531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.